List of Studies ( Metabolite:Umbelliferone sulfate)
| Study_id | Analysis_id | Study_title | Source | Species | Disease | Institute | Units(range) |
|---|---|---|---|---|---|---|---|
| ST001639 | AN002683 | Plasma Metabolomic signatures of COPD in a SPIROMICS cohort | Blood | Human | COPD | National Jewish Health | AU |
| ST002155 | AN003530 | Longitudinal metabolomic stool dynamics in primary C. difficile infections | Feces | Human | Bacterial infection | Brigham Women's Hospital | intensity |
| ST002020 | AN003290 | TIPs Metabolomics (urine) | Urine | Human | Vanderbilt University Medical Center | osmolality normalized scaled imputed | |
| ST002498 | AN004656 | Plasma Metabolomics Profiling of 580 Patients from the Weill Cornell Medicine Early Detection Research Network Prostate Cancer Cohort | Blood | Human | Cancer | Weill Cornell Medicine | peak area |
| ST001411 | AN002361 | Plasma metabolites of lipid metabolism associate with diabetic polyneuropathy in a cohort with screen-tested type 2 diabetes: ADDITION-Denmark | Blood | Human | Obesity | University of Michigan | Peak area |
| ST001412 | AN002362 | Metabolomics study in Plasma of Obese Patients with Neuropathy Identifies Potential Metabolomics Signatures | Blood | Human | Obesity | University of Michigan | Peak area |
| ST002909 | AN004777 | Plasma metabolomics reveals distinct biological and diagnostic signatures for melioidosis | Blood | Human | Melioidosis | University of Washington | Peak Area |
| ST000899 | AN001464 | Alterations in Lipid, Amino Acid, and Energy Metabolism Distinguish Crohn Disease from Ulcerative Colitis and Control Subjects by Serum Metabolomic Profiling | Blood | Human | Inflammatory bowel disease | Vanderbilt University Medical Center | raw area counts |
| ST001749 | AN002850 | REACH Metabolomics Study | Blood | Human | Alzheimers disease | University of Wisconsin - Madison | Raw area counts |
| ST002818 | AN004588 | Evaluation of Novel Candidate Filtration Markers from a Global Metabolomics Discovery for Glomerular Filtration Rate Estimation (ALTOLD) | Blood | Human | Tufts Medical Center | raw area counts rescaled to set the median equal to 1 | |
| ST002819 | AN004592 | Evaluation of Novel Candidate Filtration Markers from a Global Metabolomics Discovery for Glomerular Filtration Rate Estimation (MDRD) | Blood | Human | Tufts Medical Center | raw area counts rescaled to set the median equal to 1 | |
| ST002820 | AN004596 | Evaluation of Novel Candidate Filtration Markers from a Global Metabolomics Discovery for Glomerular Filtration Rate Estimation (AASKG1) | Blood | Human | Tufts Medical Center | raw area counts rescaled to set the median equal to 1 | |
| ST002088 | AN003408 | Plasma Metabolomic signatures of COPD in a SPIROMICS cohort: A metabolomic severity score for airflow obstructions and emphysema | Blood | Human | COPD | National Jewish Health | relativeMedian |
| ST002089 | AN003412 | Plasma metabolomic signatures of COPD: A metabolomic severity score for airflow obstruction and emphysema. | Blood | Human | COPD | National Jewish Health | relativeMedian |
| ST002017 | AN003287 | Multi-omic analysis of the microbiome and metabolome in healthy subjects (blood) | Blood | Human | Vanderbilt University Medical Center | scaled imputed | |
| ST002019 | AN003289 | TIPs Metabolomics (blood) | Blood | Human | Vanderbilt University Medical Center | scaled imputed |
